Tianmu Pharmaceutical Company (600671.SH) subsidiary received the notice of drug re-registration approval.

Wisdom Finance News APP learned that Tianmu Pharmaceutical Industry (600671.SH) has issued an announcement. The company's wholly-owned subsidiary, Huangshan Tianmu Pharmaceutical Industry Co., Ltd. (referred to as "Huangshan Tianmu"), recently received several "Drug Re-registration Approval Notices" including Liuwei Dihuang Pills issued by the Anhui Provincial Drug Administration.